Dani Stoltzfus
Corporate Officer/Principal bei NEUBASE THERAPEUTICS, INC.
Aktive Positionen von Dani Stoltzfus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Dani Stoltzfus
Ausbildung von Dani Stoltzfus
Flinders University | Doctorate Degree |
Statistik
International
Australien | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
- Börse
- Insiders
- Dani Stoltzfus
- Erfahrung